Nathalie Madeira

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?

Santiago Rodrigues-Manica, Alexandre Sepriano, Fernando Pimentel‐Santos et al. · Arthritis Research & Therapy · 2020 · 24 citations · Full text

Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

José Marona, Alexandre Sepriano, Santiago Rodrigues-Manica et al. · RMD Open · 2020 · 19 citations · Full text

Reuma.pt/vasculitis – the Portuguese vasculitis registry

Cristina Ponte, Nikita Khmelinskii, Vítor Teixeira et al. · Orphanet Journal of Rare Diseases · 2020 · 16 citations · Full text

Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study

Raquel Freitas, Fátima Godinho, Nathalie Madeira et al. · Drugs & Aging · 2020 · 15 citations

Rheumatoid Disorder, Rheumatology, Geriatrics +11

Lymphocyte subpopulations in Sjögren’s syndrome are distinct in anti-SSA-positive patients and related to disease activity

Filipe Barcelos, Catarina Martins, Nathalie Madeira et al. · Clinical Rheumatology · 2021 · 10 citations · Full text

Clinical Immunology, Rheumatology, Anti-ssa-positive Patients +13